Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC Neoadjuvant Therapy in Locally Advanced Breast Cancer
NCT01229605Phase 2Withdrawn
- Sponsor
- Tufts Medical Center
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cyclophosphamide, docetaxel in breast cancer, sponsored by Tufts Medical Center. Planned start Oct 2010; status: withdrawn.
02
Drugs
cyclophosphamidedocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01229605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229605.